Showing results (31-40 of 73) with videos related to
Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2014
Lenalidomide and rituximab for the initial treatment of patients with chronic lymphocytic leukemia: a multicenter clinical-translational study from the chronic lymphocytic leukemia research consortiumDanelle F James, Lillian Werner, Jennifer R Brown, et al.Blood|May 16, 2014
Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutationsJohn C Riches, Conor J O'Donovan, Sarah J Kingdon, et al.British Journal of Haematology|September 4, 2010
Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridizationSunita R Setlur, Chunhwa Ihm, Joelle Tchinda, et al.Cancer|May 21, 2016
A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapiesRana R McKay, Guillermo De Velasco, Lillian Werner, et al.BMC Cancer|April 18, 2015
DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumorsRichard M Bambury, Ami S Bhatt, Markus Riester, et al.Plos One|June 7, 2013
Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune responseRinath M Jeselsohn, Lillian Werner, Meredith M Regan, et al.Cancer|November 15, 2018
A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancerRana R McKay, Lillian Werner, Susanna J Jacobus, et al.The Prostate|August 2, 2017
The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancerLauren C Harshman, Lillian Werner, Abhishek Tripathi, et al.Blood|December 1, 2010
CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemiaMariela Sivina, Elena Hartmann, Thomas J Kipps, et al.Journal for Immunotherapy of Cancer|November 20, 2021
Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067Meredith M Regan, Charlene M Mantia, Lillian Werner, et al.Pageof 8